CAS No.
[22232-54-8 (Unlabeled)]
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
1-Ethoxycarbonyl-3-methyl-d3-2-thio-4-imidazoline
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90 %
Hazard Compound
No -Refer MSDS for accurate information
Carbimazole-d3 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Carbimazole-d3 usage and description
Carbimazole D3 is a synthetic medication which is used to treat hyperthyroidism, a condition in which the thyroid gland produces an excess of thyroid hormone. The drug works by inhibiting the production of thyroid hormone in the thyroid gland. Carbimazole D3 is a derivative of the drug Methimazole, which is also used to treat hyperthyroidism, but Carbimazole D3 is deuterated (contains a heavier isotope of hydrogen) which makes it useful in pharmacokinetic studies.
Carbimazole D3 is usually administered orally in the form of tablets. The dosage of Carbimazole D3 is determined by the severity of the patient's hyperthyroidism and their response to the drug. The drug is usually taken for several months, until the patient's thyroid hormone levels return to normal. Side effects of Carbimazole D3 may include nausea, vomiting, headache, and rash. In rare cases, the drug may cause more serious side effects such as liver damage or agranulocytosis (a decrease in white blood cell count).
Carbimazole D3 is a prodrug, which means that it is metabolized in the body to its active form, Methimazole. Methimazole works by inhibiting the enzyme thyroperoxidase, which is necessary for the production of thyroid hormone. Carbimazole D3 is a deuterated form of Methimazole, which means that it contains a heavier isotope of hydrogen. This makes it useful in pharmacokinetic studies, which are studies that examine how drugs are metabolized and excreted by the body. By using Carbimazole D3 instead of Methimazole, researchers can track the drug's metabolism more accurately.
